ELEVATION POINT WEALTH PARTNERS, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1744349
DENVER, CO
Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,495,954
-$5,856 QoQ
Shares Held
27,671
+10.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#672
of 2,266 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ELEVATION POINT WEALTH PARTNERS, LLC holds $156,714,234 across 14 Drug Manufacturers - General names. GILD ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
42,067 | $50,456,426 | |
| 2 | JNJ |
Johnson & Johnson
|
94,695 | $24,049,689 | |
| 3 | ABBV |
AbbVie Inc.
|
92,097 | $23,175,289 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,564 | $18,704,974 | |
| 5 | AMGN |
Amgen Inc
|
25,505 | $9,235,870 | |
| 6 | PFE |
Pfizer Inc
|
316,786 | $7,628,206 | |
| 7 | NVS |
Novartis AG
|
47,580 | $7,456,737 | |
| 8 | AZN |
Astrazeneca PLC
|
38,745 | $7,346,826 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,495,954 | 27,671 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,501,810 | 25,126 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $658,868 | 5,368 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $247,197 | 2,227 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $110,980 | 1,001 | Shares | Sole | 2026-02-03 | |
| 2022-09-30 | $7,387,315 | 119,749 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $6,774,066 | 109,595 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $6,301,640 | 105,999 | Shares | Sole | 2022-05-03 | |
| No filing history on record for this holder in this stock. | ||||||